NCT01506791View on ClinicalTrials.gov

Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Healthy
Interventions
DRUG

Desloratadine and pseudoephedrine

Desloratadine and pseudoephedrine 5/240 mg

Trial Locations (1)

33901

SFBC Ft Myers Inc, Broadway

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY